Metabonomics and Metabolomics Techniques and Their Applications in Mammalian Systems

The Handbook of Metabonomics and Metabolomics

Volumn , Issue , 2007, Pages 1-33

  Nicholson, Jeremy K ^a   Holmes, Elaine ^a   Lindon, John C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882555432     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044452841-4/50002-3     Document Type: Chapter

References (91)

1. Baldi P., Hatfield G.W. DNA Microarrays and Gene Expression 2002, 230. Cambridge University Press, Cambridge, UK.
2. Nicholson J.K., Wilson I.D. High-resolution proton magnetic resonance spectroscopy of biological fluids. Prog. NMR Spectrosc. 1989, 21:449-501.
3. 1H NMR spectra of urine. A nonlinear mapping approach to the classification of toxicological data. NMR Biomed. 1990, 3:166-172.
4. Gartland K.P.R., Beddell C.R., Lindon J.C., Nicholson J.K. The application of pattern recognition methods to the analysis and classification of toxicological data derived from proton NMR spectroscopy of urine. Mol. Pharmacol. 1991, 39:629-642.
5. Nicholson J.K., Lindon J.C., Holmes E. 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1189.
6. Nicholson J.K., Connelly J., Lindon J.C., Holmes E. Metabonomics: A platform for studying drug toxicity and gene function. Nat. Rev. Drug Disc. 2002, 1:153-162.
7. Fiehn O. Metabolics - the link between genotypes and phenotypes. Plant Mol. Biol. 2002, 48:155-171.
8. Nicholson J.K., Wilson I.D. Understanding 'global' systems biology: Metabonomics and the continuum of metabolism. Nature Rev. Drug Disc. 2003, 2:668-676.
9. Nicholson J.K., Holmes E., Lindon J.C., Wilson I.D. The challenges of modeling mammalian biocomplexity. Nature Biotech. 2004, 22:1268-1274.
10. Holmes E., Bonner F.W., Sweatman B.C., Lindon J.C., Beddell C.R., Rahr E., Nicholson J.K. NMR spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression and recovery from nephrotoxic lesions in the rat induced by mercury II chloride and 2-bromoethanamine. Mol. Pharmacol. 1992, 42:922-930.
11. Guarner F., Malagelada J.R. Gut flora in health and disease. The Lancet 2003, 360:512-519.
12. Tannock G.W. Normal Microflora 1995, Chapman and Hall.
13. Xu J., Bjursell M.K., Himrod J., Deng S., Carmichael L.K., Chaing H.C., Hooper L.V., Gordon J.I. A genomic view of the human- Bacteroides thetaiotaomicron symbiosis. Science 2003, 299:2074-2076.
14. Gilmore M.S., Ferretti J.J. The thin line between gut commensal and pathogen. Science 2003, 299:1999-2002.
15. Berg R.D. The indigenous gastrointestinal microflora. Trends Microbiol. 1996, 4:430-435.
16. Relman D.A., Falkow S. The meaning and impact of the human genome sequence for microbiology. Trends Microbiol. 2001, 9:206-208.
17. Gingell R., Bridges J.W., Williams R.T. The role of the intestinal flora in the metabolism of prontosil and neoprontosil in the rat. Xenobiotica 1971, 1:143-156.
18. Peppercorn M.A., Goldman P. Caffeic acid metabolism by bacteria of the human gastroin-testinal tract. Proc. Nat. Acad. Sci. USA 1972, 69:1413-1415.
19. Kelly D., Campbell J.I., King T.P., Grant G., Jansson E.A., Coutts A.G.P., Pettersson S., Conway S. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPARγ and RelA. Nature, Immunol. 2003, 5:104-112.
20. Phipps A.N., Stewart J., Wright B., Wilson I.D. Effect of diet on the urinary excretion of hippuric acid and other dietary derived aromatics in the rat. A complex interaction between the diet, intestinal microflora and substrate specificity. Xenobiotica 1998, 28:527-537.
21. 1H nuclear magnetic resonance spectroscopy study. Xenobiotica 2002, 32:783-794.
22. Nicholls A.W., Mortishire-Smith R.J., Nicholson J.K. NMR spectroscopic based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem. Res. Toxicol. 2003, 16:1395-1404.
23. Sheweita S.A., Mangoura S.A., Shemi A.G.El Different levels of Schistosoma mansoni infection induce changes in drug-metabolizing enzymes. J. Helminthol. 1998, 72:71-77.
24. Sheweita S.A., Mubark J., Doenhofe M.J., Mostafa M.H., Margison G.P., O'Connor P.J., Elder R.H. Changes in the expression of cytochrome P450 isoenzymes and related carcinogen metabolizing enzymes activities in Schistosoma mansoni-infected mice. J. Helminthol. 2002, 76:71-78.
25. Satarug S., Lang M.A., Yongvanit P., Sithithaworn P., Mairiang E., Mairiang P., Pelkonen P., Bartsch H., Haswell-Elkins M.R. Induction of cytochrome P450 2A6 expression in humans by the carcinogenic parasite infection, opisthorchiasis viverrini. Cancer Epidemiol Biomarkers Prev. 1996, 5:795-800.
26. Wang Y., Holmes E., Nicholson J.K., Cloarec O., Chollet J., Tanner M., Singer B.H., Utzinger J. Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc. Nat. Acad. Sci. USA 2004, 101:12676-12681.
27. Selmer T., Andrei P.I. p-hydroxyphenylacetate decarboxylase from Clostridium difficile: A novel glycyl radical enzyme catalysing the formation of p-cresol. Eur. J. Biochem. 2001, 268:1363-1372.
28. Gygi S.P., Rochon Y., Franza B.R., Aebersold R. Correlation between protein and mRNA Abundance in Yeast. Molec. Cell. Biol. 1999, 19:1720-1730.
29. Schoenheimer R. The Dynamic State of Body Constituents 1942, Harvard University Press, Boston.
30. Griffin J.L., Bonney J.L., Mann C., Hebbachi A.M., Gibbons G.F., Nicholson J.K., Shoulders C.C., Scott J. An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver. Physiol. Genomics 2004, 17:140-149.
31. Raamsdonk L.M., Teusink B., Broadhurst D., Zhang N., Hayes A., Walsh M.C., Berden J.A., Brindle K.M., Kell D.B., Rowland J.J., Westerhoff H.V., Dam K.van, Oliver S.G. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nature Biotech. 2001, 19:45-50.
32. 1H NMR spectroscopy and pattern recognition. Anal. Biochem. 2001, 295:194-202.
33. Waters N.J., Holmes E., Williams A., Waterfield C.J., Farrant R.D., Nicholson J.K. NMR and pattern recognition studies on the time-related metabolic effects of α-naphthylisothiocyanate on liver, urine and plasma in the rat: An integrative metabonomic approach. Chem. Res. Toxicol. 2001, 14:1401-1412.
34. Azmi J., Griffin J., Antti H., Shore R.F., Johansson E., Nicholson J.K., Holmes E. Metabolic trajectory characterisation of xenobiotic-induced hepatotoxic lesions using statistical batch processing of NMR data. The Analyst 2002, 127:271-276.
35. Keun H.C., Bollard M., Beckonert O., Holmes E., Lindon J.C., Nicholson J.K. Geometric trajectory analysis of metabolic responses to toxicity can define treatment-specific profiles. Chem. Res. Toxicol. 2004, 17:579-587.
36. Mortishire-Smith R.J., Skiles G.L., Lawrence J.W., Spence S., Nicholls A.W., Johnson B.A., Nicholson J.K. Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of drug-induced toxicity. Chem. Res. Toxicol. 2004, 17:165-173.
37. Lindon J.C., Nicholson J.K., Everett J.R. NMR spectroscopy of biofluids. Ann. Reports on NMR Spectrosc 1999, 38:1-88. Academic Press, Oxford, UK. G.A. Webb (Ed.).
38. Mayr M., Chung Y.L., Mayr U., Yin X.K., Ly L., Troy H., Fredericks S., Yu Y.H., Griffiths J.R., Xu Q.B. Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscl. Thromb. Vasc. Biol. 2005, 25:2135-2142.
39. Lamers R.J.A.N., Wessels E.C.H.H., van der Sandt J.J.M., Venema K., Schaafsma G., van der Greef J., van Nesselrooij J.H.J. A pilot study to investigate effects of inulin on Caco-2 cells through in vitro metabolic fingerprinting. J. Nutrition 2003, 133:3080-3084.
40. Villas-Boas S.G., Hojer-Pedersen J., Akesson M., Smedsgaard J., Nielsen J. Global metabolite analysis of yeast: Evaluation of sample preparation methods. Yeast 2005, 22:1155-1169.
41. Ippolito J.E., Xu J., Jain S.J., Moulder K., Mennerick S., Crowley J.R., Townsend R.R., Gordon J.I. An integrated functional geonomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proc. Nat. Acad. Sci. USA 2005, 102:9901-9906.
42. 1H NMR and MAS NMR spectroscopy. Chem. Res. Toxicol. 2002, 15:1351-1359.
43. Kaderbhai N.N., Broadhurst D.I., Ellis D.I., Kell D.B. Functional genomics via metabolic footprinting: Monitoring metabolite secretion by Escherichia coli tryptophan metabolism mutants using FT-IR and direct injection electrospray mass spectrometry. Comp. Funct. Genom. 2003, 4:376-391.
44. Gamache P.H., Meyer D.F., Granger M.C., Acworth I.N. Metabolomic applications of electrochemistry/mass spectrometry. J. Am. Soc. Mass Spectrom. 2004, 15:1717-1726.
45. T.D.W. Claridge, High-Resolution NMR Techniques in Organic Chemistry. Elsevier Science, Oxford, UK, pp. 384. ISBN: 0080427995.
46. 1H NMR spectroscopy of biological fluids. Anal. Chem. 1996, 68:3370-3376.
47. 13C NMR spectroscopy of human blood plasma. Anal. Chem. 1995, 67:793-811.
48. 13C NMR spectroscopy of urine for metabonomic studies. Anal. Chem. 2002, 74:4588-4593.
49. Price K.E., Vandaveer S.S., Lunte C.E., Larive C.K. Tissue targeted metabonomics: Metabolic profiling by microdialysis sampling and microcoil NMR. J. Pharmaceut. Biomed. Anal. 2005, 38:904-909.
50. 1H nuclear magnetic resonance analysis of intact prostatic hyperplastic and tumour tissues. Anal. Commun. 1998, 35:113-115.
51. 1H NMR spectroscopic studies on intact rat renal cortex and medulla. Magn. Reson. Med. 1999, 41:1108-1118.
52. Cheng L.L., Chang I.W., Louis D.N., Gonzalez R.G. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res. 1998, 58:1825-1832.
53. Yang J., Xu G., Zheng Y., Kong H., Pang T., Lv S., Yang Q. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J. Chromatogr., B 2004, 813:59-65.
54. Morris M., Watkins S.M. Focused metabolomic profiling in the drug development process: Advances from lipid profiling. Curr. Op. Chem. Biol. 2005, 9:407-412.
55. Wilson I.D., Nicholson J.K., Castro-Perez J., Granger J.H., Johnson K.A., Smith B.W., Plumb R.S. High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J. Proteome Res. 2005, 4:591-598.
56. Soga T., Ohashi Y., Ueno Y., Nasaoka H., Tomita M., Nishioka T. Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J. Proteome Res. 2003, 2:488-494.
57. Lindon J.C., Nicholson J.K., Wilson I.D. Directly-coupled HPLC-NMR and HPLC-NMR-MS in pharmaceutical research and development. J. Chromatog., B 2000, 748:233-258.
58. Lindon J.C., Holmes E., Nicholson J.K. Pattern recognition methods and applications in biomedical magnetic resonance. Prog. NMR Spectrosc. 2001, 39:1-40.
59. Wold H. Partial Least Squares. Encyclopedia of Statistical Sciences 1985, 6:581-591. John Wiley & Sons, New York, USA. S. Kotz, N.L. Johnson (Eds.).
60. Trygg J., Wold S. Orthogonal projections to latent structures (O-PLS). J. Chemonet. 2002, 16:119-128.
61. Holmes E., Nicholson J.K., Tranter G. Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks. Chem. Res. Toxicol. 2001, 14:182-191.
62. Kell D.B. Metabolomics and machine learning: explanatory analysis of complex metabolome data using genetic programming to produce simple, robust rules. Mol. Biol. Rep. 2002, 29:237-241.
63. 1H NMR data sets. Anal. Chem. 2005, 77:1282-1289.
64. Crockford D.J., Holmes E., Lindon J.C., Plumb R.S., Zirah S., Bruce S.J., Rainville P., Stumpf C.L., Nicholson J.K. Statistical Heterospectroscop Y (SHY), a new approach to the integrated analysis of NMR and UPLC-MS datasets: Application in metabonomic toxicology studies. Anal. Chem. 2006, 78:363-371.
65. Lindon J.C., Nicholson J.K., Holmes E., Keun H.C., Craig A., Pearce J.T.M., Bruce S.J., Hardy N., Sansone S.-A., Antii H., Jonsson P., Daykin C., Navarange M., Beger R.D., Verheij E.R., Amberg A., Baunsgaard D., Cantor G.H., Lehman-McKeeman L., Earll M., Wold S., Johansson E., Haselden J.N., Kramer K., Thomas C., Lindberg J., Schuppe-Koistinen I., Wilson I.D., Reily M.D., Robertson D.G., Senn H., Krotzky A., Kochhar S., Powell J., van der Ouderaa F., Plumb R., Schaefer H., Spraul M. Summary recommendations for standardization and reporting of metabolic analyses. Nature Biotech. 2005, 23:833-838.
66. Jenkins H., Hardy N., Beckmann M., Draper J., Smith A.R., Taylor J., Fiehn O., Goodacre R., Bino R.J., Hall R., Kopka J., Lane G.A., Lange B.M., Liu J.R., Mendes P., Nikolau B.J., Oliver S.G., Paton N.W., Rhee S., Roessner-Tunali U., Saito K., Smedsgaard J., Summer L.W., Wang T., Walsh S., Wurtele E.S., Kell D.B. A proposed framework for the description of plant metabolomics experiments and their results. Nature Biotech. 2004, 22:1601-1606.
67. Castle A.L., Fiehn O., Kaddurah-Daouk R., Lindon J.C. Metabolomics standards workshop and the development of international standards for reporting metabolomics experimental results. Briefings in Bioinformatics 2006, 7:159-165.
68. Bollard M.E., Stanley E.G., Lindon J.C., Nicholson J.K., Holmes E. NMR-based metabonomics approaches for evaluating physiological influences on biofluid composition. NMR Biomed. 2005, 18:143-162.
69. Plumb R.S., Granger J.H., Stumpf C.L., Johnson K.A., Smith B.W., Gaulitz S., Wilson I.D., Castro-Perez J. A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: Application to age, gender and diurnal variation in normal/Zucker obese rats and black, white and nude mice. Analyst 2005, 130:844-849.
70. German J.B., Roberts M.A., Watkins S.M. Genomics and metabolomics as markers for the interaction of diet and health: Lessons from lipids. J. Nutrition 2003, 133:2078S-2083S.
71. Lehtimaki K.K., Valonen P.K., Griffin J.L., Vaisanen T.H., Grohn O.H.J., Kettunen M.I., Vepsalainen J., Yla-Herttuala S., Nicholson J., Kauppinen R.A. Metabolite changes in BT4C rat gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death as studied by H-1 NMR spectroscopy in vivo, ex vivo, and in vitro. J. Biol. Chem. 2003, 278:45915-45923.
72. Robosky L.C., Wells D.F., Egnash L.A., Manning M.L., Reily M.D., Robertson D.G. Metabonomic identification of two distinct phenotypes in Sprague-Dawley (Crl: CD(SD)) rats. Toxicol. Sci. 2005, 87:277-284.
73. Lindon J.C., Holmes E., Nicholson J.K. Toxicological applications of magnetic resonance. Prog. NMR Spectrosc. 2004, 45:109-143.
74. 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamycin-induced nephrotoxicity in the rat. Biomarkers 2005, 10:173-187.
75. Lindon J.C., Nicholson J.K., Holmes E., Antti H., Bollard M.E., Keun H., Beckonert O., Ebbels T.M., Reily M.D., Robertson D., Stevens G.J., Luke P., Breau A.P., Cantor G.H., Bible R.H., Niederhauser U., Senn H., Schlotterbeck G., Sidelmann U.G., Laursen S.M., Tymiak A., Car B.D., Lehman-McKeeman L., Colet J.M., Loukaci A., Thomas C. Contemporary issues in toxicology: The role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharmacol. 2003, 187:137-146.
76. 1H NMR-based metabonomic urinalysis. Chem. Res. Toxicol. 2002, 15:1380-1386.
77. Keun H.C., Ebbels T.M.D., Bollard M.E., Beckonert O., Antti H., Holmes E., Lindon J.C., Nicholson J.K. Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles. Chem. Res. Toxicol. 2004, 17:579-587.
78. Ebbels T., Keun H., Beckonert O., Antti H., Bollard M., Holmes E., Lindon J., Nicholson J. Toxicity classification from metabonomic data using a density superposition approach: 'CLOUDS'. Anal. Chim. Acta 2003, 490:109-122.
79. Lindon J.C., Keun H.C., Ebbels T.M.D., Pearce J.M.T., Holmes E., Nicholson J.K. The Consortium for Metabonomic Toxicology (COMET): Aims, Activities and Achievements. Pharmacogenomics 2005, 6:691-699.
80. Bollard M.E., Keun H.C., Beckonert O., Ebbels T.M.D., Antti H., Nicholls A.W., Shockcor J.P., Cantor G.H., Stevens G., Lindon L.C., Holmes E., Nicholson J.K. Comparative metabonomics of differential hydrazine toxicity in the rat and mouse. Toxicol. Appl. Pharmacol. 2005, 204:135-151.
81. Moolenaar S.H., Engelke U.F.H., Wevers R.A. Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism. Ann. Clin. Biochem. 2003, 40:16-24.
82. Coen M., O'Sullivan M., Bubb W.A., Kuchel P.W., Sorrell T. Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis. Clin. Infect. Disease 2005, 41:1582-1590.
83. Dunne V.G., Bhattachayya S., Besser M., Rae C., Griffin J.L. Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: A pattern-recognition H-1 NMR study. NMR Biomed. 2005, 18:24-33.
84. Swanson M.G., Vigneron D.B., Tabatabai Z.L., Males R.G., Schmitt L., Carroll P.R., James J.K., Hurd R.E., Kurhanewicz J. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn. Reson. Med. 2003, 50:944-954.
85. 1H nuclear magnetic resonance spectroscopy. J. Pharmaceut. Biomed. Anal. 1998, 17:125-132.
86. Sitter B., Sonnewald U., Spraul M., Fjosne H.E., Gribbestad I.S. High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed. 2002, 15:327-337.
87. 1H HR-MAS spectroscopy of intact biopsy samples in vitro. Magma 1999, 8:121-128.
88. Jones G.L.A.H., Sang E., Goddard C., Mortishire-Smith R.J., Sweatman B.C., Haselden J.N., Davies K., Grace A.A., Clarke K., Griffin J.L. A functional analysis of mouse models of cardiac disease through metabolic profiling. J. Biol Chem. 2005, 280:7530-7539.
89. Odunsi K., Wollman R.M., Ambrosone C.B., Hutson A., McCann S.E., Tammela J., Geisler J.P., Miller G., Sellers T., Cliby W., Qian F., Keitz B., Intengan M., Lele S., Alderfer J.L. Detection of epithelial ovarian cancer using H-1-NMR-based metabonomics. Int. J. Cancer 2005, 113:782-788.
90. Brindle J.T., Antti H., Holmes E., Tranter G., Nicholson J.K., Bethell H.W.L., Clarke S., Schofield P.M., McKilligin E., Mosedale D.E., Grainger D.J. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using H-1 NMR-based metabonomics. Nature Med. 2002, 8:1439-1445.
91. Clayton T.A., Lindon J.C., Antti H., Charuel C., Hanton G., Provost J.-P., Le Net J.-L., Baker D., Walley R.J., Everett J.R., Nicholson J.K. Pharmaco-metabonomic phenotyping and personalised drug treatment. Nature 2006, 440:1535-1542.